Doseology Sciences Inc. (DOSEF) Stock
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Doseology Sciences Inc.
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders. Customers can acquire these items directly through its official e-commerce platform, doseology.com. Founded in 2019, Doseology Sciences Inc. is headquartered in Kelowna, Canada.
Doseology Sciences Inc. is headquartered in CA.
Doseology Sciences Inc. (DOSEF) stock trades at $0.11 with a market capitalization of $501357. The stock is valued at a price-to-earnings (P/E) ratio of -1.32, price-to-book of 2.16, price-to-sales of 10.80. Over the past 52 weeks the stock has ranged between $0.01 and $1.50, and currently trades 92.7% below its 52-week high.
On profitability, Doseology Sciences Inc. generates a return on equity (ROE) of -85.01%, return on capital employed of -107.98%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: doseology.com